ID   PTPRB_HUMAN             Reviewed;        1997 AA.
AC   P23467; B7ZKS8; B7ZKT0; C9JX87; F5H3G6; Q14D85; Q3MIV7;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   28-JUN-2023, entry version 211.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase beta;
DE            Short=Protein-tyrosine phosphatase beta;
DE            Short=R-PTP-beta;
DE            EC=3.1.3.48;
DE   AltName: Full=Vascular endothelial protein tyrosine phosphatase;
DE            Short=VE-PTP;
DE   Flags: Precursor;
GN   Name=PTPRB; Synonyms=PTPB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LYS-94 AND GLY-127.
RC   TISSUE=Placenta;
RX   PubMed=2170109; DOI=10.1002/j.1460-2075.1990.tb07523.x;
RA   Krueger N.X., Streuli M., Saito H.;
RT   "Structural diversity and evolution of human receptor-like protein tyrosine
RT   phosphatases.";
RL   EMBO J. 9:3241-3252(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4), AND VARIANT
RP   LYS-94.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [7]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=19116766; DOI=10.1007/s10456-008-9126-0;
RA   Yacyshyn O.K., Lai P.F.H., Forse K., Teichert-Kuliszewska K., Jurasz P.,
RA   Stewart D.J.;
RT   "Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human
RT   endothelial cells.";
RL   Angiogenesis 12:25-33(2009).
RN   [8]
RP   FUNCTION.
RX   PubMed=19136612; DOI=10.1096/fj.08-123810;
RA   Mellberg S., Dimberg A., Bahram F., Hayashi M., Rennel E., Ameur A.,
RA   Westholm J.O., Larsson E., Lindahl P., Cross M.J., Claesson-Welsh L.;
RT   "Transcriptional profiling reveals a critical role for tyrosine phosphatase
RT   VE-PTP in regulation of VEGFR2 activity and endothelial cell
RT   morphogenesis.";
RL   FASEB J. 23:1490-1502(2009).
RN   [9]
RP   INTERACTION WITH TEK.
RX   PubMed=19451274; DOI=10.1083/jcb.200811159;
RA   Winderlich M., Keller L., Cagna G., Broermann A., Kamenyeva O., Kiefer F.,
RA   Deutsch U., Nottebaum A.F., Vestweber D.;
RT   "VE-PTP controls blood vessel development by balancing Tie-2 activity.";
RL   J. Cell Biol. 185:657-671(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 1676-1965 IN COMPLEX WITH
RP   INHIBITOR SULFAMIC ACID, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=17139078; DOI=10.1107/s0907444906037784;
RA   Evdokimov A.G., Pokross M., Walter R., Mekel M., Cox B., Li C., Bechard R.,
RA   Genbauffe F., Andrews R., Diven C., Howard B., Rastogi V., Gray J.,
RA   Maier M., Peters K.G.;
RT   "Engineering the catalytic domain of human protein tyrosine phosphatase
RT   beta for structure-based drug discovery.";
RL   Acta Crystallogr. D 62:1435-1445(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1662-1973 IN COMPLEX WITH
RP   INHIBITOR SULFAMIC ACID.
RX   PubMed=16759857; DOI=10.1016/j.bmcl.2006.05.074;
RA   Amarasinghe K.K.D., Evdokimov A.G., Xu K., Clark C.M., Maier M.B.,
RA   Srivastava A., Colson A.-O., Gerwe G.S., Stake G.E., Howard B.W.,
RA   Pokross M.E., Gray J.L., Peters K.G.;
RT   "Design and synthesis of potent, non-peptidic inhibitors of HPTPbeta.";
RL   Bioorg. Med. Chem. Lett. 16:4252-4256(2006).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1686-1971.
RX   PubMed=19167335; DOI=10.1016/j.cell.2008.11.038;
RA   Barr A.J., Ugochukwu E., Lee W.H., King O.N.F., Filippakopoulos P.,
RA   Alfano I., Savitsky P., Burgess-Brown N.A., Mueller S., Knapp S.;
RT   "Large-scale structural analysis of the classical human protein tyrosine
RT   phosphatome.";
RL   Cell 136:352-363(2009).
CC   -!- FUNCTION: Plays an important role in blood vessel remodeling and
CC       angiogenesis. Not necessary for the initial formation of blood vessels,
CC       but is essential for their maintenance and remodeling. Can induce
CC       dephosphorylation of TEK/TIE2, CDH5/VE-cadherin and KDR/VEGFR-2.
CC       Regulates angiopoietin-TIE2 signaling in endothelial cells. Acts as a
CC       negative regulator of TIE2, and controls TIE2 driven endothelial cell
CC       proliferation, which in turn affects blood vessel remodeling during
CC       embryonic development and determines blood vessel size during perinatal
CC       growth. Essential for the maintenance of endothelial cell contact
CC       integrity and for the adhesive function of VE-cadherin in endothelial
CC       cells and this requires the presence of plakoglobin (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:19116766,
CC       ECO:0000269|PubMed:19136612}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Monomer. Interacts with TEK (PubMed:19451274). Interacts via
CC       fibronectin type-III 17 domain with CDH5. Detected in a complex with
CC       CNTN1 and NRCAM (By similarity). Interacts (phosphorylated form) with
CC       FYN and GRB2 (By similarity). {ECO:0000250|UniProtKB:B2RU80,
CC       ECO:0000269|PubMed:19451274}.
CC   -!- INTERACTION:
CC       P23467; P00533: EGFR; NbExp=3; IntAct=EBI-1265766, EBI-297353;
CC       P23467; P04626: ERBB2; NbExp=2; IntAct=EBI-1265766, EBI-641062;
CC       P23467; P10912: GHR; NbExp=3; IntAct=EBI-1265766, EBI-286316;
CC       P23467; P27361: MAPK3; NbExp=2; IntAct=EBI-1265766, EBI-73995;
CC       P23467; P08581: MET; NbExp=2; IntAct=EBI-1265766, EBI-1039152;
CC       P23467; Q02763: TEK; NbExp=3; IntAct=EBI-1265766, EBI-2257090;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P23467-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23467-2; Sequence=VSP_038521;
CC       Name=3;
CC         IsoId=P23467-3; Sequence=VSP_040484;
CC       Name=4;
CC         IsoId=P23467-4; Sequence=VSP_053944;
CC   -!- INDUCTION: Up-regulated by hypoxia. {ECO:0000269|PubMed:19116766}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 3 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X54131; CAA38066.1; -; mRNA.
DR   EMBL; BX648245; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC025569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97254.1; -; Genomic_DNA.
DR   EMBL; BC101679; AAI01680.1; -; mRNA.
DR   EMBL; BC113463; AAI13464.1; -; mRNA.
DR   EMBL; BC143356; AAI43357.1; -; mRNA.
DR   EMBL; BC143360; AAI43361.1; -; mRNA.
DR   CCDS; CCDS44943.1; -. [P23467-3]
DR   CCDS; CCDS44944.1; -. [P23467-1]
DR   CCDS; CCDS55845.1; -. [P23467-2]
DR   CCDS; CCDS55846.1; -. [P23467-4]
DR   PIR; S12050; S12050.
DR   RefSeq; NP_001103224.1; NM_001109754.3. [P23467-3]
DR   RefSeq; NP_001193900.1; NM_001206971.2. [P23467-2]
DR   RefSeq; NP_001193901.1; NM_001206972.2. [P23467-4]
DR   RefSeq; NP_001317133.1; NM_001330204.1.
DR   RefSeq; NP_002828.3; NM_002837.5. [P23467-1]
DR   PDB; 2AHS; X-ray; 2.10 A; A/B=1686-1971.
DR   PDB; 2H02; X-ray; 2.30 A; A/B=1662-1973.
DR   PDB; 2H03; X-ray; 1.65 A; A=1676-1970.
DR   PDB; 2H04; X-ray; 2.30 A; A=1662-1973.
DR   PDB; 2HC1; X-ray; 1.30 A; A=1676-1970.
DR   PDB; 2HC2; X-ray; 1.40 A; A=1676-1970.
DR   PDB; 2I3R; X-ray; 1.85 A; A/B=1662-1973.
DR   PDB; 2I3U; X-ray; 1.85 A; A=1662-1973.
DR   PDB; 2I4E; X-ray; 1.75 A; A/B=1662-1973.
DR   PDB; 2I4G; X-ray; 1.65 A; A=1662-1973.
DR   PDB; 2I4H; X-ray; 2.15 A; A=1662-1973.
DR   PDB; 2I5X; X-ray; 1.70 A; A/B=1662-1973.
DR   PDBsum; 2AHS; -.
DR   PDBsum; 2H02; -.
DR   PDBsum; 2H03; -.
DR   PDBsum; 2H04; -.
DR   PDBsum; 2HC1; -.
DR   PDBsum; 2HC2; -.
DR   PDBsum; 2I3R; -.
DR   PDBsum; 2I3U; -.
DR   PDBsum; 2I4E; -.
DR   PDBsum; 2I4G; -.
DR   PDBsum; 2I4H; -.
DR   PDBsum; 2I5X; -.
DR   AlphaFoldDB; P23467; -.
DR   SMR; P23467; -.
DR   BioGRID; 111751; 30.
DR   CORUM; P23467; -.
DR   IntAct; P23467; 38.
DR   MINT; P23467; -.
DR   STRING; 9606.ENSP00000334928; -.
DR   BindingDB; P23467; -.
DR   ChEMBL; CHEMBL2706; -.
DR   DrugBank; DB08678; (4-ETHYLPHENYL)SULFAMIC ACID.
DR   DrugBank; DB07068; (4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID.
DR   DrugBank; DB16353; Razuprotafib.
DR   DrugBank; DB07127; {4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID.
DR   DrugBank; DB06989; {4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID.
DR   GuidetoPHARMACOLOGY; 1851; -.
DR   DEPOD; PTPRB; -.
DR   GlyCosmos; P23467; 26 sites, No reported glycans.
DR   GlyGen; P23467; 26 sites.
DR   iPTMnet; P23467; -.
DR   PhosphoSitePlus; P23467; -.
DR   BioMuta; PTPRB; -.
DR   DMDM; 317373518; -.
DR   EPD; P23467; -.
DR   jPOST; P23467; -.
DR   MassIVE; P23467; -.
DR   MaxQB; P23467; -.
DR   PaxDb; P23467; -.
DR   PeptideAtlas; P23467; -.
DR   ProteomicsDB; 26267; -.
DR   ProteomicsDB; 54098; -. [P23467-1]
DR   ProteomicsDB; 54099; -. [P23467-2]
DR   ProteomicsDB; 54100; -. [P23467-3]
DR   Antibodypedia; 29475; 117 antibodies from 24 providers.
DR   DNASU; 5787; -.
DR   Ensembl; ENST00000261266.9; ENSP00000261266.5; ENSG00000127329.16. [P23467-1]
DR   Ensembl; ENST00000334414.11; ENSP00000334928.6; ENSG00000127329.16. [P23467-3]
DR   Ensembl; ENST00000538708.5; ENSP00000438927.1; ENSG00000127329.16. [P23467-4]
DR   Ensembl; ENST00000550857.5; ENSP00000447302.1; ENSG00000127329.16. [P23467-2]
DR   GeneID; 5787; -.
DR   KEGG; hsa:5787; -.
DR   MANE-Select; ENST00000334414.11; ENSP00000334928.6; NM_001109754.4; NP_001103224.1. [P23467-3]
DR   UCSC; uc001swb.6; human. [P23467-1]
DR   AGR; HGNC:9665; -.
DR   CTD; 5787; -.
DR   DisGeNET; 5787; -.
DR   GeneCards; PTPRB; -.
DR   HGNC; HGNC:9665; PTPRB.
DR   HPA; ENSG00000127329; Low tissue specificity.
DR   MIM; 176882; gene.
DR   neXtProt; NX_P23467; -.
DR   OpenTargets; ENSG00000127329; -.
DR   PharmGKB; PA34010; -.
DR   VEuPathDB; HostDB:ENSG00000127329; -.
DR   eggNOG; KOG0791; Eukaryota.
DR   GeneTree; ENSGT00940000156088; -.
DR   HOGENOM; CLU_000787_0_0_1; -.
DR   InParanoid; P23467; -.
DR   OMA; TRHQTNT; -.
DR   OrthoDB; 5402037at2759; -.
DR   PhylomeDB; P23467; -.
DR   TreeFam; TF351926; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   PathwayCommons; P23467; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P23467; -.
DR   SIGNOR; P23467; -.
DR   BioGRID-ORCS; 5787; 10 hits in 1176 CRISPR screens.
DR   ChiTaRS; PTPRB; human.
DR   EvolutionaryTrace; P23467; -.
DR   GeneWiki; PTPRB; -.
DR   GenomeRNAi; 5787; -.
DR   Pharos; P23467; Tchem.
DR   PRO; PR:P23467; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P23467; protein.
DR   Bgee; ENSG00000127329; Expressed in endothelial cell and 181 other tissues.
DR   ExpressionAtlas; P23467; baseline and differential.
DR   Genevisible; P23467; HS.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0045296; F:cadherin binding; IPI:ARUK-UCL.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0001525; P:angiogenesis; IBA:GO_Central.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0008347; P:glial cell migration; IEA:Ensembl.
DR   GO; GO:1990264; P:peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity; IBA:GO_Central.
DR   GO; GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:ProtInc.
DR   CDD; cd00063; FN3; 12.
DR   CDD; cd14617; R-PTPc-B; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 15.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR041201; PTPRJ_TM.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   PANTHER; PTHR46957; CYTOKINE RECEPTOR; 1.
DR   PANTHER; PTHR46957:SF2; RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE BETA; 1.
DR   Pfam; PF00041; fn3; 15.
DR   Pfam; PF18861; PTP_tm; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 17.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 16.
DR   PROSITE; PS50853; FN3; 12.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Angiogenesis; Glycoprotein; Hydrolase;
KW   Membrane; Phosphoprotein; Protein phosphatase; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..1997
FT                   /note="Receptor-type tyrosine-protein phosphatase beta"
FT                   /id="PRO_0000025436"
FT   TOPO_DOM        23..1621
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1622..1642
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1643..1997
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          23..111
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          112..207
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          203..288
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          291..378
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          379..471
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          467..552
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          556..641
FT                   /note="Fibronectin type-III 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          642..729
FT                   /note="Fibronectin type-III 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          730..829
FT                   /note="Fibronectin type-III 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          819..906
FT                   /note="Fibronectin type-III 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          909..1001
FT                   /note="Fibronectin type-III 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          995..1083
FT                   /note="Fibronectin type-III 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1087..1175
FT                   /note="Fibronectin type-III 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1173..1260
FT                   /note="Fibronectin type-III 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1260..1356
FT                   /note="Fibronectin type-III 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1357..1448
FT                   /note="Fibronectin type-III 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1458..1554
FT                   /note="Fibronectin type-III 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1703..1963
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        1904
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000255|PROSITE-ProRule:PRU10044,
FT                   ECO:0000269|PubMed:17139078"
FT   BINDING         1870
FT                   /ligand="substrate"
FT   BINDING         1904..1910
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1948
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1981
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RU80"
FT   CARBOHYD        28
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        53
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        75
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        198
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        267
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        321
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        414
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        421
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        479
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        544
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        574
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        598
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        652
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        721
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        829
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1040
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1096
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1163
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1185
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1212
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1274
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1367
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1470
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1474
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1518
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..18
FT                   /note="MLSHGAGLALWITLSLLQ -> MEAEFYMVILTCLIFRNSEGFQIVHVQKQQ
FT                   CLFKNEKVVVGSCNRTIQNQQWMWTEDEKLLHVKSALCLAISNSSRGPSRSAILDRCSQ
FT                   APRWTCYDQEGFLEVENASLFLQKQGSRVVVKKARKYLHSWMKIDVNKEGKLVNESLCL
FT                   QKAGLGAEVSVRSTRNTAPPQILTTFNAVPDGLVFLIRNTTEAFIRNAAENYSQNSSER
FT                   QHPNLHMTGITDTSWVLSTTQPFSSTTEE (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_040484"
FT   VAR_SEQ         377..466
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038521"
FT   VAR_SEQ         997..1086
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_053944"
FT   VARIANT         94
FT                   /note="R -> K (in dbSNP:rs2252784)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:2170109"
FT                   /id="VAR_062251"
FT   VARIANT         127
FT                   /note="S -> G (in dbSNP:rs2465811)"
FT                   /evidence="ECO:0000269|PubMed:2170109"
FT                   /id="VAR_062252"
FT   VARIANT         395
FT                   /note="V -> A (in dbSNP:rs36027530)"
FT                   /id="VAR_057135"
FT   VARIANT         415
FT                   /note="D -> E (in dbSNP:rs2165627)"
FT                   /id="VAR_057136"
FT   VARIANT         939
FT                   /note="T -> M (in dbSNP:rs2304821)"
FT                   /id="VAR_057137"
FT   VARIANT         1032
FT                   /note="T -> I (in dbSNP:rs34902691)"
FT                   /id="VAR_057138"
FT   VARIANT         1934
FT                   /note="G -> A (in dbSNP:rs17226367)"
FT                   /id="VAR_057139"
FT   CONFLICT        261
FT                   /note="T -> S (in Ref. 1; CAA38066)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        666
FT                   /note="L -> V (in Ref. 1; CAA38066)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        926
FT                   /note="V -> A (in Ref. 2; BX648245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1559
FT                   /note="C -> R (in Ref. 1; CAA38066)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1685..1687
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1688..1709
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   TURN            1710..1716
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   TURN            1720..1723
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1728..1730
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1740..1742
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1743..1745
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1753..1756
FT                   /evidence="ECO:0007829|PDB:2AHS"
FT   STRAND          1757..1763
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1766..1769
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1771..1775
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   TURN            1780..1782
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1783..1792
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1797..1800
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1804..1806
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1818..1821
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1823..1825
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1828..1837
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1839..1849
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1856..1865
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1870..1872
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1877..1893
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1894..1896
FT                   /evidence="ECO:0007829|PDB:2H03"
FT   STRAND          1900..1903
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1905..1908
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1909..1926
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   STRAND          1928..1930
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1932..1940
FT                   /evidence="ECO:0007829|PDB:2HC1"
FT   HELIX           1950..1968
FT                   /evidence="ECO:0007829|PDB:2HC1"
SQ   SEQUENCE   1997 AA;  224301 MW;  76E67B4A6109AA0F CRC64;
     MLSHGAGLAL WITLSLLQTG LAEPERCNFT LAESKASSHS VSIQWRILGS PCNFSLIYSS
     DTLGAALCPT FRIDNTTYGC NLQDLQAGTI YNFRIISLDE ERTVVLQTDP LPPARFGVSK
     EKTTSTSLHV WWTPSSGKVT SYEVQLFDEN NQKIQGVQIQ ESTSWNEYTF FNLTAGSKYN
     IAITAVSGGK RSFSVYTNGS TVPSPVKDIG ISTKANSLLI SWSHGSGNVE RYRLMLMDKG
     ILVHGGVVDK HATSYAFHGL TPGYLYNLTV MTEAAGLQNY RWKLVRTAPM EVSNLKVTND
     GSLTSLKVKW QRPPGNVDSY NITLSHKGTI KESRVLAPWI TETHFKELVP GRLYQVTVSC
     VSGELSAQKM AVGRTFPDKV ANLEANNNGR MRSLVVSWSP PAGDWEQYRI LLFNDSVVLL
     NITVGKEETQ YVMDDTGLVP GRQYEVEVIV ESGNLKNSER CQGRTVPLAV LQLRVKHANE
     TSLSIMWQTP VAEWEKYIIS LADRDLLLIH KSLSKDAKEF TFTDLVPGRK YMATVTSISG
     DLKNSSSVKG RTVPAQVTDL HVANQGMTSS LFTNWTQAQG DVEFYQVLLI HENVVIKNES
     ISSETSRYSF HSLKSGSLYS VVVTTVSGGI SSRQVVVEGR TVPSSVSGVT VNNSGRNDYL
     SVSWLLAPGD VDNYEVTLSH DGKVVQSLVI AKSVRECSFS SLTPGRLYTV TITTRSGKYE
     NHSFSQERTV PDKVQGVSVS NSARSDYLRV SWVHATGDFD HYEVTIKNKN NFIQTKSIPK
     SENECVFVQL VPGRLYSVTV TTKSGQYEAN EQGNGRTIPE PVKDLTLRNR STEDLHVTWS
     GANGDVDQYE IQLLFNDMKV FPPFHLVNTA TEYRFTSLTP GRQYKILVLT ISGDVQQSAF
     IEGFTVPSAV KNIHISPNGA TDSLTVNWTP GGGDVDSYTV SAFRHSQKVD SQTIPKHVFE
     HTFHRLEAGE QYQIMIASVS GSLKNQINVV GRTVPASVQG VIADNAYSSY SLIVSWQKAA
     GVAERYDILL LTENGILLRN TSEPATTKQH KFEDLTPGKK YKIQILTVSG GLFSKEAQTE
     GRTVPAAVTD LRITENSTRH LSFRWTASEG ELSWYNIFLY NPDGNLQERA QVDPLVQSFS
     FQNLLQGRMY KMVIVTHSGE LSNESFIFGR TVPASVSHLR GSNRNTTDSL WFNWSPASGD
     FDFYELILYN PNGTKKENWK DKDLTEWRFQ GLVPGRKYVL WVVTHSGDLS NKVTAESRTA
     PSPPSLMSFA DIANTSLAIT WKGPPDWTDY NDFELQWLPR DALTVFNPYN NRKSEGRIVY
     GLRPGRSYQF NVKTVSGDSW KTYSKPIFGS VRTKPDKIQN LHCRPQNSTA IACSWIPPDS
     DFDGYSIECR KMDTQEVEFS RKLEKEKSLL NIMMLVPHKR YLVSIKVQSA GMTSEVVEDS
     TITMIDRPPP PPPHIRVNEK DVLISKSSIN FTVNCSWFSD TNGAVKYFTV VVREADGSDE
     LKPEQQHPLP SYLEYRHNAS IRVYQTNYFA SKCAENPNSN SKSFNIKLGA EMESLGGKCD
     PTQQKFCDGP LKPHTAYRIS IRAFTQLFDE DLKEFTKPLY SDTFFSLPIT TESEPLFGAI
     EGVSAGLFLI GMLVAVVALL ICRQKVSHGR ERPSARLSIR RDRPLSVHLN LGQKGNRKTS
     CPIKINQFEG HFMKLQADSN YLLSKEYEEL KDVGRNQSCD IALLPENRGK NRYNNILPYD
     ATRVKLSNVD DDPCSDYINA SYIPGNNFRR EYIVTQGPLP GTKDDFWKMV WEQNVHNIVM
     VTQCVEKGRV KCDHYWPADQ DSLYYGDLIL QMLSESVLPE WTIREFKICG EEQLDAHRLI
     RHFHYTVWPD HGVPETTQSL IQFVRTVRDY INRSPGAGPT VVHCSAGVGR TGTFIALDRI
     LQQLDSKDSV DIYGAVHDLR LHRVHMVQTE CQYVYLHQCV RDVLRARKLR SEQENPLFPI
     YENVNPEYHR DPVYSRH
//
